Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Ammonia Solution, Strong. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL563368 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL29030469 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL30213850 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL15452891 | 1.00 | — | — | |
| Ammonia Solution, Strong SCHEMBL1524073 | 0.87 | — | — | |
| Ammonia Solution, Strong SCHEMBL15452922 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL1226036 | 0.82 | — | — | |
| Ammonia Solution, Strong SCHEMBL29365419 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL22685 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL21825132 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10801070-B2 | Compositions and methods for diagnosing, evaluating and treating cancer | THE BROAD INSTITUTE, INC. (US) | 2020-10-13 | — | — | US | claimed |
| EP-3312183-B1 | DEUTERATED MORPHINE DERIVATIVES FOR USE IN ANALGESIA | UNIV SZEGEDI (HU) | 2020-06-17 | — | — | EP | claimed |
| EP-3312183-A1 | DEUTERATED MORPHINE DERIVATIVES | Szegedi Tudományegyetem (HU) | 2018-04-25 | — | — | EP | claimed |
| EP-2986612-B1 | DEUTERATED MORPHINE DERIVATIVES | Szegedi Tudományegyetem (HU) | 2017-06-07 | — | — | EP | claimed |
| US-9644074-B2 | Benzene polycarboxylic acid compounds and their use as drug | RINNOVATION APS (DK) | 2017-05-09 | — | — | US | claimed |
| EP-2831151-B1 | BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG | RDINNOVATION APS (DK) | 2016-12-14 | — | — | EP | claimed |
| US-9447108-B2 | Deuterated morphine derivatives | Szegedi Tudományegyetem (HU) | 2016-09-20 | — | — | US | claimed |
| US-20160052931-A1 | DEUTERATED MORPHINE DERIVATIVES | Szegedi Tudományegyetem (HU) | 2016-02-25 | — | — | US | claimed |
| EP-2986612-A1 | DEUTERATED MORPHINE DERIVATIVES | Szegedi Tudományegyetem (HU) | 2016-02-24 | — | — | EP | claimed |
| US-20160017104-A1 | Benzene Polycarboxylic Acid Compounds and Their Use as Drug | RDINNOVATION APS (DK) | 2016-01-21 | — | — | US | claimed |
| EP-2831151-A1 | BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG | RDInnovation ApS (DK) | 2015-02-04 | — | — | EP | claimed |
| WO-2014170704-A1 | DEUTERATED MORPHINE DERIVATIVES | Szegedi Tudományegyetem (HU) | 2014-10-23 | — | — | WO | claimed |
| WO-2013143549-A1 | BENZENE POLYCARBOXYLIC ACID COMPOUNDS AND THEIR USE AS DRUG | RDINNOVATION APS (DK) | 2013-10-03 | — | — | WO | claimed |
| EP-2210616-A1 | Multifunctional stealth nanoparticles for biomedical use | Centre National de la Recherche Scientifique (FR) | 2010-07-28 | — | — | EP | claimed |
| US-7419818-B2 | Organic conductor | FUJI XEROX CO., LTD (JP) | 2008-09-02 | — | — | US | claimed |
| US-7238794-B2 | Organic conductor | FUJI XEROX CO., LTD. (JP) | 2007-07-03 | — | — | US | claimed |
| US-20030170692-A1 | Organic conductor | FUJI XEROX CO., LTD. (JP) | 2003-09-11 | — | — | US | claimed |
| EP-1324352-A2 | Organic conductor | FUJI XEROX CO., LTD. (JP) | 2003-07-02 | — | — | EP | claimed |
| EP-4737504-A2 | CATIONIC LIPID, LIPOSOME CONTAINING CATIONIC LIPID, AND NUCLEIC-ACID PHARMACEUTICAL COMPOSITION CONTAINING LIPOSOME AND FORMULATION AND APPLICATION THEREOF | Xiamen Sinopeg Biotech Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-4410544-A | Platinum-diamine complexes, a method for the preparation of a medicine using such a platinum-diamine complex for the treatment of malignant tumor in mice | Nederlandse Centrale Organisatie voor Toegespastnatuurwetenschappeliukond erzoek (NL) | 1983-10-18 | — | — | US | disclosed |